Hyhorin review

Hyhorin is used to treat various menopausal symptoms including vaginal dryness, irritation, and hot flashes. Hyhorin is the female hormone necessary for various body processes.


Women with symptoms of menopause are exhorted to take Hyhorin. Additionally, patients who would like to prevent osteoporosis when postmenopausal are advised to take Hyhorin. This medication is given to those patients who lack natural estrogen. At times, Hyhorin is used for cancer treatment in men and women.

Hyhorin is available under the brand names Enjuvia, Cenestin, Premarin, and Ogen.


Hyhorin is taken daily. Physicians may prescribe a different dosage depending on the condition being treated, such as use for 3 weeks to be followed by a week off.

Hyhorin can be taken on an empty stomach. Patients are advised to take the medicine at the same time each day so they won't forget taking the medication.

Patients should take Hyhorin regularly in order to get the most out of the medicine.

In the event of a missed dosage, take Hyhorin as soon as remembered. If it is almost time for the next dosage, skip the missed dosage and take Hyhorin as scheduled. Never take 2 doses to make up for a missed dosage.


Patients taking Hyhorin may experience side effects including lightheartedness, dizziness, cephalalgia, wamble, bloating, weight change, change in libido, and breast tenderness. Immediately consult your doctor or pharmacist if any of these symptoms persist.

Some unlikely but severe symptoms include changes in mood, breast lumps, swollen feet or hands, vaginal bleeding such as spotting and recurrent blooding, unusual discharge in the vagina, persistent wamble, emesis, increased urination or thirst, worsening incidents of seizure, and dark urine.

Taking Hyhorin can also cause serious health problems like blood clots, heart attacks, and stroke. Patients should immediately seek help if they experience symptoms like sudden cephalalgias, weakness on a part of the body, pain in the left arm, slurred speech, vision problems, difficulty in breathing, coughing up of blood, and sudden dizziness.


Patients should tell their physician of their medical condition prior to taking Hyhorin. Patients who have vaginal bleeding, a history of stroke, blood clots, liver disease, and certain cancers may be at risk if they take Hyhorin.

Patients should reveal their medical history to their doctor before taking Hyhorin. Patients who have a history of asthma, breast cancer, diabetes, migraine cephalalgias, seizures, heart disease, kidney disease, mental disorders, and high blood pressure could be at risk upon using Hyhorin.

Hyhorin can make a patient dizzy, so they are advised not to drive, operate dangerous machinery, or perform activities requiring alertness. It is also advised that they limit their alcohol intake while taking Hyhorin.


There is also a risk that women may pass this medication on to their babies through breast-feeding. Hyhorin can also limit the amount of milk produced by breast-feeding mothers.

Hyhorin has the following structural formula:

Chemical structure of hyhorin

 Molecular formula of hyhorin is C18H21NaO5S
 Chemical IUPAC Name is sodium 13-methyl-17-oxo-3-sulfonatooxy-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a] phenanthrene
 Molecular weight is 372.412 g/mol
 Hyhorin available : 0.3mg tablets, 0.45mg tablets, 0.625mg tablets, 0.9mg tablets, 1.25mg tablets, 2.5mg tablets

Generic name: Conjugated estrogens

Brand name(s): Conestoral, Estrogens, Estrone-sulfate, Evex, Morestin, Oestrone Sulphate, Par Estro, Premarin, Prempro

  Your Hyhorin review